Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Brazil
Summary - Dna-Derived Insulin Lispro *
Deadline - Nov 25, 2024
GT reference number - 97838338
Product classification - Medical equipments, pharmaceuticals and personal care products
Address - Brazil
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 97838338
Document Type - Tender Notices
Description - notice_title: * Electronic Bidding * Dna-Derived Insulin Lispro *local title:: * Licitação Eletrônica * INSULINA LISPRO DERIVADA DE ADN * lot_details: 1: Completa INSULINA lispro derivada de ADN recombinante contendo 100 unidades U-100 por mL em f raco de vidro com 10 mL de solucao. A embalagem deve conter "venda proibida pelo comercio". Apresentar registro dos produtos na Anvisa e Certificado de Boas Praticas, Fabricacao e Controle - CBPFC do fabricante conforme resolucao Anvisa nº 460/99. Em caso de fabricante fora do mercosul, apresentar documento do pais de origem traduzido por tradutor oficial.
Gt Ref Id - 97838338
Deadline - Nov 25, 2024
Similar Tenders :
Join to access thousands of business opportunities
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database
